Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vitamin B12 for Prevention of Chemotherapy-induced Peripheral Neuropathy in Gynecological Cancer
TCTR20210104003Phase 3Completed
- Sponsor
- Rajavithi Hospital
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyanocobalamin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Rajavithi Hospital. Started Jan 2021; status: completed.
02
Drugs
cyanocobalamin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on TCTR20210104003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210104003.